BLLN Company Profile and Key Details

NASDAQ : BLLN

BillionToOne

$79.36

-3.6-4.34%

Open: 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

BillionToOne, Inc. (BLLN) stock declined over -4.34%, trading at $79.36 on NASDAQ, down from the previous close of $82.96. The stock opened at $79.94, fluctuating between $76.28 and $84.90 in the recent session.

Stock Snapshot

82.96

Prev. Close

3.65B

Market Cap

76.28

Day Low

566.86

P/E Ratio

0.14

EPS (TTM)

N/A

Cash Flow per Share

79.94

Open

45.97M

Number of Shares

84.8955

Day High

N/A

Free Float in %

N/A

Book Value

355.01K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2026	79.94	84.90	76.28	79.36	362.71K
Apr 01, 2026	77.64	85.00	77.64	82.96	611.29K
Mar 31, 2026	71.13	79.11	71.13	78.94	300K
Mar 30, 2026	69.55	72.12	67.00	70.11	294.88K
Mar 27, 2026	70.01	72.34	67.70	69.55	304.58K
Mar 25, 2026	74.46	77.31	72.29	77.00	237.83K
Mar 24, 2026	79.00	79.01	72.00	74.08	224.32K
Mar 23, 2026	76.00	80.38	76.00	79.59	269.15K
Mar 20, 2026	74.88	76.47	72.59	76.00	238.69K
Mar 19, 2026	71.27	74.08	70.70	74.00	179.18K
Mar 18, 2026	69.65	73.62	69.06	71.27	248.46K
Mar 17, 2026	72.09	74.25	69.02	69.76	278.58K
Mar 16, 2026	69.77	73.86	69.56	71.34	170.53K
Mar 13, 2026	64.03	69.11	64.03	69.11	230.66K
Mar 12, 2026	66.04	68.24	61.96	64.03	423.71K
Mar 11, 2026	70.20	72.22	64.74	67.36	475.84K
Mar 10, 2026	72.11	72.11	69.50	70.20	186.81K
Mar 09, 2026	72.20	74.08	68.50	72.11	403.92K
Mar 06, 2026	71.38	76.53	68.94	73.51	455.46K
Mar 03, 2026	78.53	84.92	73.83	83.14	284.56K

Contact Details

Menlo Park, CA 94025

United States

https://www.billiontoone.com 650 460 2551

About Company

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a test that provides longitudinal determination of cancer burden through methylation assessment. The company was incorporated in 2016 and is headquartered in Menlo Park, California.

Stock Peers

IDXX

4.89+0.87%

IDEXX Laboratories, Inc.$569.55 MEDP

8.86+1.81%

Medpace Holdings, Inc.$498.34 NTRA

4.77+2.35%

Natera, Inc.$207.98 ILMN

0.75+0.59%

Illumina, Inc.$127.38 ICLR

2.77+2.49%

ICON Public Limited Company$114.19 EXAS

Exact Sciences Corporation$104.91 GH

2.68+2.94%

Guardant Health, Inc.$93.83 GRAL

1.39+2.59%

GRAIL, Inc.$54.99 RDNT

-0.52-0.94%

RadNet, Inc.$54.79 TWST

0.67+1.35%

Twist Bioscience Corporation$50.21

Company Overview

BillionToOne, Inc. (NASDAQ:BLLN) closed at $79.36 USD, losing -$3.60 (-4.34%) from the previous close of $82.96. The stock is currently mid-range between its 52-week high and low $61.96 and $138.70. With a market capitalization of about $3.65 billion, BillionToOne, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~6.30). Key stats such as the average daily volume over the past year has been around 281.39 thousand shares, in line with its 52-week average. Headquartered in Menlo Park, CA, BillionToOne, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Oguzhan Atay, the company employs approximately 620 people and listed since November 06, 2025. BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 -15.01%, SMA50 -18.7%, SMA200 -24.15%). The stock’s 14-day RSI is 34.74 (weak momentum), while the ATR of 6.83 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -48.51% below its high and over 4.85% above its low. Average 10-day trading volume of 333.66 thousand shares is slightly above the 3-month average of 264.52 thousand, indicating heightened recent market interest.

Valuation Metrics

BillionToOne, Inc. trades at a P/E ratio of 1167.03, slightly above the S&P 500 average, with a price-to-sales ratio of 12.47 and a price-to-book ratio of 7.9 trading at moderately above to book value. The P/FCF stands at 242.22, also above market averages.

Dividend & Fair Value

BillionToOne, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $116.90. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 6 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $160.00 to $100.00. The high target offers 101.61% upside. The low target suggests 26.01% downside. The mean target is $136.00. This offers 71.37% upside. BillionToOne, Inc. earnings surprise history is a mixed track record. The quarter that ended December 09, 2025, missed forecasts by -37.5%.

Financial & Profitability Overview

Over the trailing twelve months, BillionToOne has not generated any revenue.
On valuation metrics, BillionToOne trades at a P/E of 1167.03, P/S of 12.47 and P/B of 7.90. The current ratio is 11.69 and quick ratio is 11.32. Operationally, the company’s inventory turnover is 5.51 and cash conversion cycle is 88.91 days. Debt-to-equity is 0.23, supported by a cash flow-to-debt ratio of 0.23.

Price Forecast & Outlook

Our AI price prediction model suggests that BillionToOne, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.23%, with price expected at $79.54 by April 16, 2026, within a range of $73.61 to $85.71 3-Month Outlook: Projected fall of -68.41%, reaching $25.07 by July 01, 2026, with a range of $24.00 to $26.33. 1-Year Outlook: Projected loss of -26.17%, with price at $58.59 by April 02, 2027, within a range of $57.07 to $59.68.

Key Takeaways

BillionToOne, Inc. (NASDAQ:BLLN) shares are flat 5.02% year-to-date currently trading near 52-week highs band. Valuation shows BillionToOne, Inc. trading at a premium to the broader market with a P/E of 1167.03. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $136.00, suggesting 71.37% upside. Our AI forecast model points to short-term strength (0.23% over two weeks), a medium-term fall (-68.41% over three months), and a longer-term loss (-26.17% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current BillionToOne, Inc. (BLLN) stock price?

BillionToOne, Inc. (NASDAQ: BLLN) stock price is $79.36 in the last trading session. During the trading session, BLLN stock reached the peak price of $84.90 while $76.28 was the lowest point it dropped to. The percentage change in BLLN stock occurred in the recent session was -4.34% while the dollar amount for the price change in BLLN stock was - $3.60.

BLLN's industry and sector of operation?

The NASDAQ listed BLLN is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. BillionToOne, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BLLN?

No Data

How BLLN did perform over past 52-week?

BLLN's closing price is 28.08% higher than its 52-week low of $61.96 where as its distance from 52-week high of $138.70 is -42.78%.

How many employees does BLLN have?

Number of BLLN employees currently stands at 620.

Link for BLLN official website?

Official Website of BLLN is: https://www.billiontoone.com

How do I contact BLLN?

BLLN could be contacted at phone 650 460 2551 and can also be accessed through its website. BLLN operates from 1035 O’Brien Drive, Menlo Park, CA 94025, United States.

How many shares of BLLN are traded daily?

BLLN stock volume for the day was 355.01K shares. The average number of BLLN shares traded daily for last 3 months was 281.39K.

What is the market cap of BLLN currently?

The market value of BLLN currently stands at $3.65B with its latest stock price at $79.36 and 45.97M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	620
Beta	6.3
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Medical - Diagnostics & Research

BLLN Company Profile and Key Details

BillionToOne

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Valuation Metrics

Company Overview

Earnings & Analyst Outlook

Technical Performance

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Financial & Profitability Overview